| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | US7897150 Canine lymphoma cell line and uses thereof |
| 03/01/2011 | CA2688760A1 Transformed human pluripotent stem cells and associated methods |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2400664C A method for generating hypermutable plants |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 02/27/2011 | CA2677139A1 Life sciences technologies |
| 02/24/2011 | WO2011022725A2 Mimotopes of hiv and uses thereof |
| 02/24/2011 | WO2011022507A1 Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells |
| 02/24/2011 | WO2011022451A1 Human skin explant culture system and use therefor |
| 02/24/2011 | WO2011022413A2 Reprogramming a cell by activation of the endogenous transcription factor network |
| 02/24/2011 | WO2011022077A2 A nucleic acid cassette for producing recombinant antibodies |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021666A1 Recombinant dna molecule encoding 5'utr capable of preventing inhibition of translation under environmental stresses |
| 02/24/2011 | WO2011021618A1 Cell preservation method |
| 02/24/2011 | WO2011021616A1 Novel protein having β-glucosidase activity, and use thereof |
| 02/24/2011 | WO2011021558A1 Process for production of bioartificial organ |
| 02/24/2011 | WO2011021194A2 Pericyte progenitor cells and methods of generating and using same |
| 02/24/2011 | WO2011020163A1 Plant gene expression |
| 02/24/2011 | WO2011020155A1 Anti p2x7 receptor antibodies and fragments thereof |
| 02/24/2011 | WO2011002727A9 Methods of producing humanized non-human mammals |
| 02/24/2011 | WO2010141622A3 Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate |
| 02/24/2011 | WO2010136508A3 Stem cell targeting |
| 02/24/2011 | WO2010111443A3 Omentum as a source of stromal/stem cells and medical treatments using omentum stromal/stem cells |
| 02/24/2011 | WO2010111409A3 Pluripotent stem cells |
| 02/24/2011 | WO2010110602A3 Method for regenerating dopaminergic neurons in the substantia nigra pars compacta using human adult stem cells or precursor cells |
| 02/24/2011 | WO2010108126A3 Reprogramming compositions and methods of using the same |
| 02/24/2011 | WO2010107192A3 Isolating method for umbilical cord blood-derived pluripotent stem cells expressing znf281 |
| 02/24/2011 | WO2010104588A3 Compositions and methods for characterizing and treating neoplasia |
| 02/24/2011 | WO2010088456A3 Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
| 02/24/2011 | WO2010007502A8 Platelet fraction deriving from placental blood |
| 02/24/2011 | WO2010007372A8 Transgenic rodent expressing truncated disc1 |
| 02/24/2011 | US20110047660 Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc |
| 02/24/2011 | US20110047659 Transgenic Plants With Enhanced Agronomic Traits |
| 02/24/2011 | US20110047657 Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | US20110047655 Novel frt recombination sites and methods of use |
| 02/24/2011 | US20110047653 Cultivars of the poppy papaver bracteatum that produce seed capsules and thebaine in the first growing season |
| 02/24/2011 | US20110047652 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 02/24/2011 | US20110047651 Transformation and engineered trait modification in miscanthus species |
| 02/24/2011 | US20110047649 Nitrogen responsiveness in plants through the expression of pathways for the formation and catabolism of novel n-rich compounds |
| 02/24/2011 | US20110047648 Promoters and methods thereof |
| 02/24/2011 | US20110047647 Functional expression of shuffled yeast nitrate transporter (ynt1) in maize to improve nitrate uptake under low nitrate environment |
| 02/24/2011 | US20110047644 Compositions and methods for the modification of gene transcription |
| 02/24/2011 | US20110047642 New cucumber plants with a compact growing habit |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110046982 Methods and compositions related to viral inhibition |
| 02/24/2011 | US20110046352 Disease-resistant plants and method of constructing the same |
| 02/24/2011 | US20110046211 Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents |
| 02/24/2011 | US20110046209 RNA-Induced Translational Silencing and Cellular Apoptosis |
| 02/24/2011 | US20110046208 Nucleolar targeting of therapeutics against hiv |
| 02/24/2011 | US20110046206 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046201 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/24/2011 | US20110046200 Use of antisense oligonucleotides to effect translation modulation |
| 02/24/2011 | US20110046149 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/24/2011 | US20110046092 Small molecules for neuronal differentiation of embryonic stem cells |
| 02/24/2011 | US20110046090 Modulation of neurogenesis with gaba agents and gaba analogs |
| 02/24/2011 | US20110046070 Gene expression inhibitor selective for matrix metalloproteinase-9 gene |
| 02/24/2011 | US20110046067 COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USE |
| 02/24/2011 | US20110046066 Inhibitors of iap |
| 02/24/2011 | US20110045590 Calcium-influx inhibitory factor and method of isolation thereof |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045588 Method for culturing human periosteum |
| 02/24/2011 | US20110045587 Toxin peptide therapeutic agents |
| 02/24/2011 | US20110045586 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 02/24/2011 | US20110045585 Kit for fluorometric analysis |
| 02/24/2011 | US20110045572 Protein variants having modified immunogenicity |
| 02/24/2011 | US20110045569 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n- acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 02/24/2011 | US20110045568 Method for restoring bmp-receptor signaling in a cell |
| 02/24/2011 | US20110045538 Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support |
| 02/24/2011 | US20110045537 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors |
| 02/24/2011 | US20110045536 Mammalian expression vector |
| 02/24/2011 | US20110045535 Activator for Blood Coagulation Factor VII Promoter and Utilization of the Same |
| 02/24/2011 | US20110045534 Nucleic Acid Cassette For Producing Recombinant Antibodies |
| 02/24/2011 | US20110045532 Protein production method |
| 02/24/2011 | US20110045519 Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof |
| 02/24/2011 | US20110045500 Cell culture method and screening method |
| 02/24/2011 | US20110045497 Novel acidic glycan markers of human cells |
| 02/24/2011 | US20110045477 Human skin explant culture system and use therefor |
| 02/24/2011 | US20110045098 Excitatory glycine receptors and methods |
| 02/24/2011 | US20110045081 Magnetic, paramagnetic and/or superparamagnetic nanoparticles |
| 02/24/2011 | US20110045080 Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto |
| 02/24/2011 | US20110045071 Generation of a novel type of anti-inflammatory macrophages for clinical use |
| 02/24/2011 | US20110045060 Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 02/24/2011 | US20110045058 Transfection reagent |
| 02/24/2011 | US20110045053 Isolated population of luminal stem cells that give rise to prostate cancer and methods of using same |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045048 Bone graft and scaffolding materials immobilized with type i collagen binding peptides |
| 02/24/2011 | US20110045046 Glycopeptides and methods of making and using them |
| 02/24/2011 | US20110045045 Production of and uses for decellularized lung tissue |
| 02/24/2011 | US20110045044 Compositions for repair of defects in tissues, and methods of making the same |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045005 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/24/2011 | US20110045003 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044995 Anti-hiv monoclonal antibody |
| 02/24/2011 | US20110044994 Human immunodeficiency virus (hiv)-neutralizing antibodies |